Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04449744 · ClinicalTrials.gov registry record · NA
Evaluating Adaptive Dispenser Initiation Protocols for MySafeRx During Post-detox Buprenorphine Treatment- a Pilot Study
A NA study, sponsored by University of South Florida.
- Completed
- Registry status
- NA
- Development phase
- 19
- Enrollment target
NCT04449744 is a NA study that has completed, run by University of South Florida. The registered enrollment target is 19 participants.
The verdict
NCT04449744, a NA study, has completed, sponsored by University of South Florida.
- COMPLETED
- Registry status
- NA
- Development phase
- 19 participants
- Enrollment target
Study Summary
Opioid overdoses are a significant problem nationwide and novel interventions that can prevent overdose by improving buprenorphine treatment for opioid use disorder are a public health priority. This study will both investigate the effects of starting remote motivational enhancement during inpatient detoxification on rates of engagement in Buprenorphine/ Naloxone (B/N) treatment and evaluate the impact of MySafeRx, a mobile device application which integrates remote motivational coaching with daily observed dosing from secure electronic pill dispensers at home via videoconference, on treatment retention and overdose prevention. Broad dissemination of this new intervention could help communities across the nation expand and advance their capacity to increase B/N treatment engagement and retention, enhance medication adherence, and prevent overdose.
Interventions
- OTHER MySafeRx Inspire Plus
- OTHER MySafeRx Inspire Flex
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 19 participants |
| Start Date | 2020-07-13 |
| Est. Completion | 2021-09-30 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04449744
The ClinicalTrials.gov registry entry for NCT04449744 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 19 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of South Florida, which has 252 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which MySafeRx Inspire Plus is the first listed.
NCT04449744 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04449744 about?
NCT04449744 is a clinical study titled "Evaluating Adaptive Dispenser Initiation Protocols for MySafeRx During Post-detox Buprenorphine Treatment- a Pilot Study". Opioid overdoses are a significant problem nationwide and novel interventions that can prevent overdose by improving buprenorphine treatment for opioid use disorder are a public health priority. This study will both investigate the effects of starting remote motivational enhancement during inpatient...
What is the current status of trial NCT04449744?
This trial is currently completed. It is a NA study. The enrollment target is 19 participants. The study started on 2020-07-13. Estimated completion is 2021-09-30.
What interventions are being tested in trial NCT04449744?
The interventions under investigation include: MySafeRx Inspire Plus (OTHER), MySafeRx Inspire Flex (OTHER).
Who is sponsoring clinical trial NCT04449744?
This trial is sponsored by University of South Florida, which has 252 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.